GENERALIZED LIPODYSTROPHY
Clinical trials for GENERALIZED LIPODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED LIPODYSTROPHY trials appear
Sign up with your email to follow new studies for GENERALIZED LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for tots with rare fat disorder: trial tests lifesaving drug
Disease control Recruiting nowThis study is testing a drug called metreleptin in children under 6 years old who have a rare condition called generalized lipodystrophy, which causes severe problems with fat storage, diabetes, and high blood fats. The main goal is to see if the drug safely lowers blood sugar an…
Matched conditions: GENERALIZED LIPODYSTROPHY
Phase: PHASE3 • Sponsor: Amryt Pharma • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug trial aims to control rare fat disorder
Disease control Recruiting nowThis study is testing an investigational drug called mibavademab in people with generalized lipodystrophy, a rare disorder where the body cannot store fat properly. The main goals are to see if the drug can improve high blood sugar and high fat levels in the blood, reduce fat in …
Matched conditions: GENERALIZED LIPODYSTROPHY
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC